首页> 外文期刊>Journal of Zhejiang University. Science, B >A robust statistical procedure to discover expression biomarkers using microarray genomic expression data
【24h】

A robust statistical procedure to discover expression biomarkers using microarray genomic expression data

机译:使用微阵列基因组表达数据发现表达生物标志物的可靠统计程序

获取原文
获取原文并翻译 | 示例
           

摘要

Microarray has become increasingly popular biotechnology in biological and medical researches, and has been widely applied in classification of treatment subtypes using expression patterns of biomarkers. We developed a statistical procedure to identify expression biomarkers for treatment subtype classification by constructing an F-statistic based on Henderson method III. Monte Carlo simulations were conducted to examine the robustness and efficiency of the proposed method. Simulation results showed that our method could provide satisfying power of identifying differentially expressed genes (DEGs) with false discovery rate (FDR) lower than the given type I error rate. In addition, we analyzed a leukemia dataset collected from 38 leukemia patients with 27 samples diagnosed as acute lymphoblastic leukemia (ALL) and 11 samples as acute myeloid leukemia (AML). We compared our results with those from the methods of significance analysis of microarray (SAM) and microarray analysis of variance (MAANOVA). Among these three methods, only expression biomarkers identified by our method can precisely identify the three human acute leukemia subtypes.
机译:芯片已成为生物学和医学研究中越来越流行的生物技术,并已广泛用于利用生物标志物的表达模式对治疗亚型进行分类。我们通过建立基于亨德森方法III的F统计量,开发了一种统计程序来鉴定用于治疗亚型分类的表达生物标志物。进行了蒙特卡洛模拟,以检验所提出方法的鲁棒性和效率。仿真结果表明,我们的方法可以提供令人满意的识别差表达率(FDR)低于给定I型错误率的差异表达基因(DEG)的能力。此外,我们分析了从38名白血病患者收集的白血病数据集,其中27个样品被诊断为急性淋巴细胞白血病(ALL),而11个样品被诊断为急性髓细胞性白血病(AML)。我们将结果与微阵列显着性分析(SAM)和方差微阵列分析(MAANOVA)的方法进行了比较。在这三种方法中,只有通过我们的方法鉴定出的表达生物标记物才能准确鉴定出三种人类急性白血病亚型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号